272 related articles for article (PubMed ID: 24220243)
1. Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.
Mémin E; Hoque M; Jain MR; Heller DS; Li H; Cracchiolo B; Hanauske-Abel HM; Pe'ery T; Mathews MB
Cancer Res; 2014 Jan; 74(2):552-62. PubMed ID: 24220243
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
Hoque M; Hanauske-Abel HM; Palumbo P; Saxena D; D'Alliessi Gandolfi D; Park MH; Pe'ery T; Mathews MB
Retrovirology; 2009 Oct; 6():90. PubMed ID: 19825182
[TBL] [Abstract][Full Text] [Related]
3. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
Kang KR; Kim YS; Wolff EC; Park MH
J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
[TBL] [Abstract][Full Text] [Related]
4. Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.
Cáceres CJ; Angulo J; Contreras N; Pino K; Vera-Otarola J; López-Lastra M
Antiviral Res; 2016 Oct; 134():192-206. PubMed ID: 27633452
[TBL] [Abstract][Full Text] [Related]
5. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
Fujimura K; Wright T; Strnadel J; Kaushal S; Metildi C; Lowy AM; Bouvet M; Kelber JA; Klemke RL
Cancer Res; 2014 Nov; 74(22):6671-81. PubMed ID: 25261239
[TBL] [Abstract][Full Text] [Related]
6. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
7. The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells.
Liu Z; Teng L; Gao L; Wang H; Su Y; Li J
Biochem Biophys Res Commun; 2018 Sep; 504(1):6-12. PubMed ID: 30170728
[TBL] [Abstract][Full Text] [Related]
8. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
[TBL] [Abstract][Full Text] [Related]
9. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
Park MH
J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
[TBL] [Abstract][Full Text] [Related]
10. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
Wolff EC; Kang KR; Kim YS; Park MH
Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
[TBL] [Abstract][Full Text] [Related]
11. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
[TBL] [Abstract][Full Text] [Related]
12. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
Park MH; Kar RK; Banka S; Ziegler A; Chung WK
Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
[TBL] [Abstract][Full Text] [Related]
13. Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.
Epis MR; Giles KM; Kalinowski FC; Barker A; Cohen RJ; Leedman PJ
J Biol Chem; 2012 Oct; 287(42):35251-35259. PubMed ID: 22908221
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.
Park JH; Aravind L; Wolff EC; Kaevel J; Kim YS; Park MH
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):51-6. PubMed ID: 16371467
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gene expression by translation factor eIF5A: Hypusine-modified eIF5A enhances nonsense-mediated mRNA decay in human cells.
Hoque M; Park JY; Chang YJ; Luchessi AD; Cambiaghi TD; Shamanna R; Hanauske-Abel HM; Holland B; Pe'ery T; Tian B; Mathews MB
Translation (Austin); 2017; 5(2):e1366294. PubMed ID: 29034140
[TBL] [Abstract][Full Text] [Related]
16. The Drosophila deoxyhypusine hydroxylase homologue nero and its target eIF5A are required for cell growth and the regulation of autophagy.
Patel PH; Costa-Mattioli M; Schulze KL; Bellen HJ
J Cell Biol; 2009 Jun; 185(7):1181-94. PubMed ID: 19546244
[TBL] [Abstract][Full Text] [Related]
17. Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins.
Nguyen S; Leija C; Kinch L; Regmi S; Li Q; Grishin NV; Phillips MA
J Biol Chem; 2015 Aug; 290(32):19987-98. PubMed ID: 26082486
[TBL] [Abstract][Full Text] [Related]
18. Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder.
Ziegler A; Steindl K; Hanner AS; Kar RK; Prouteau C; Boland A; Deleuze JF; Coubes C; Bézieau S; Küry S; Maystadt I; Le Mao M; Lenaers G; Navet B; Faivre L; Tran Mau-Them F; Zanoni P; Chung WK; Rauch A; Bonneau D; Park MH
Am J Hum Genet; 2022 Aug; 109(8):1549-1558. PubMed ID: 35858628
[TBL] [Abstract][Full Text] [Related]
19. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
Ofek P; Yeini E; Arad G; Danilevsky A; Pozzi S; Luna CB; Dangoor SI; Grossman R; Ram Z; Shomron N; Brem H; Hyde TM; Geiger T; Satchi-Fainaro R
Int J Cancer; 2023 Aug; 153(3):654-668. PubMed ID: 37141410
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice.
Kar RK; Hanner AS; Starost MF; Springer D; Mastracci TL; Mirmira RG; Park MH
J Biol Chem; 2021 Nov; 297(5):101333. PubMed ID: 34688659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
